$400 Million is the total value of Foyston, Gordon, & Payne Inc's 58 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BKNG | Buy | Booking Holdings Inc. | $15,929,000 | +21.8% | 6,710 | +12.3% | 3.98% | +28.0% |
| KEYS | Buy | Keysight Technologies Inc. | $10,944,000 | +6.4% | 66,613 | +0.0% | 2.73% | +11.8% |
| BAX | Buy | Baxter International Inc. | $9,797,000 | +8.1% | 121,808 | +8.2% | 2.45% | +13.6% |
| GWW | Buy | W.W. Grainger Inc. | $8,195,000 | -8.1% | 20,850 | +2.5% | 2.05% | -3.4% |
| CTVA | Buy | Corteva Inc. | $5,751,000 | +8.5% | 136,659 | +14.3% | 1.44% | +14.0% |
| LIN | Buy | Linde PLC | $5,604,000 | +5.6% | 19,103 | +4.1% | 1.40% | +10.9% |
| GNTX | Buy | Gentex Corp. | $5,594,000 | +79.8% | 169,632 | +80.4% | 1.40% | +88.9% |
| RTX | Buy | Raytheon Technologies Corp. | $5,148,000 | +0.8% | 59,889 | +0.1% | 1.29% | +5.9% |
| SONY | Buy | Sony Group Corp. - Spon ADR | $5,031,000 | +20.6% | 45,500 | +6.1% | 1.26% | +26.7% |
| CME | Buy | CME Group Inc. | $3,716,000 | -8.5% | 19,217 | +0.6% | 0.93% | -3.9% |
| BDX | Buy | Becton Dickinson & Co. | $3,715,000 | +28.7% | 15,113 | +27.4% | 0.93% | +35.3% |
| VVV | Buy | Valvoline Inc. | $3,435,000 | +11.9% | 110,158 | +16.5% | 0.86% | +17.5% |
| UL | Buy | Unilever PLC - ADR | $1,601,000 | -6.8% | 29,536 | +0.6% | 0.40% | -2.0% |
| USB | New | U.S. Bancorp. | $206,000 | – | 3,463 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.